Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.

Renaud FeltenValérie Devauchelle-PensecRaphaèle SerorPierre DuffauDavid SaadounEric HachullaHatron Pierre YvesCarine SalliotAleth PerdrigerJacques MorelArsène MékinianOlivier VittecoqJean-Marie BerthelotEmanuelle DernisVeronique Le GuernPhilippe DieudéClaire LarrocheChristophe RichezThierry MartinCharles ZarnitskyGilles BlaisonPierre KiefferFrançois MaurierAzeddine DellalStephanie RistEmmanuel AndresAnne ContisEmmanuel ChatelusChristelle SordetJean SibiliaCécile ArnoldMira Y TawkOuafaa AberkaneLise HolterbachPatrice CacoubAlain SarauxXavier MarietteNicolas MeyerJacques-Eric Gottenberg

Published in: Annals of the rheumatic diseases (2020)

NCT01782235.

Keyphrases

double blind
placebo controlled
clinical trial
study protocol
phase iii
phase ii
case report
disease activity
rheumatoid arthritis
binding protein
cross sectional